MedPath
HSA Approval

KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG

SIN15818P

KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG

KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG

September 26, 2019

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

ZUELLIG PHARMA PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C03AA03, C09CA10

xc 03 aa 03, c 09 ca 10

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

BORYUNG CORPORATION

Active Ingredients

Fimasartan Potassium Trihydrate eqv Fimasartan Potassium

60.00 mg

Fimasartan

Hydrochlorothiazide

12.5 mg

Hydrochlorothiazide

Documents

Package Inserts

Kanarb Plus Film Coated Tablet PI.pdf

Approved: January 27, 2023

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG - HSA Approval | MedPath